ONCOMED PHARMACEUTICALS

oncomed-pharmaceuticals-logo

OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as รขโ‚ฌล“cancer stem cellsรขโ‚ฌย. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.

#SimilarOrganizations #People #Financial #Website #More

ONCOMED PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2004-08-01

Address:
Redwood City, California, United States

Country:
United States

Website Url:
http://www.oncomed.com

Total Employee:
51+

Status:
Active

Contact:
650-995-8200

Email Addresses:
[email protected]

Total Funding:
210.15 M USD

Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Amazon Route 53 DigiCert SSL Pound Sterling Amazon SSL GoDaddy


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

pharmagap-inc-logo

Pharmagap Inc.

Pharmagap is a company that develops therapeutic drugs for the treatment of cancer.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

vencerx-therapeutic-logo

Vencerx Therapeutic

Vencerx Therapeutics is a biotechnology company developing targeted therapeutics for the autism spectrum


Current Advisors List

denise-pollard-knight_image

Denise Pollard-Knight Board of Directors @ OncoMed Pharmaceuticals
Board_member

jack-w-lasersohn_image

Jack W. Lasersohn Board of Directors @ OncoMed Pharmaceuticals
Board_member

jonathan-root_image

Jonathan Root Board of Directors @ OncoMed Pharmaceuticals
Board_member

perry-karsen_image

Perry Karsen Member of the Board of Directors @ OncoMed Pharmaceuticals
Board_member

deepika-r-pakianathan_image

Deepika R Pakianathan Board Member @ OncoMed Pharmaceuticals
Board_member

deepika-r-pakianathan_image

Deepika R Pakianathan Board of Directors @ OncoMed Pharmaceuticals
Board_member
2008-01-01

terry-gould_image

Terry Gould Board of Directors @ OncoMed Pharmaceuticals
Board_member

larry-lasky_image

Larry Lasky Board of Directors @ OncoMed Pharmaceuticals
Board_member

Current Employees Featured

angie-park_image

Angie Park
Angie Park Sr. Director Immunotherapy @ OncoMed Pharmaceuticals
Sr. Director Immunotherapy

jakob-dupont_image

Jakob Dupont
Jakob Dupont Senior Vice President, Chief Medical Officer @ OncoMed Pharmaceuticals
Senior Vice President, Chief Medical Officer

Founder


max-wicha_image

Max Wicha

not_available_image

Michael F. Clarke

Stock Details


Company's stock symbol is NASDAQ:OMED

Investors List

morgenthaler-ventures_image

Morgenthaler Ventures

Morgenthaler Ventures investment in Series B - OncoMed Pharmaceuticals

phase4-ventures_image

Phase4 Ventures

Phase4 Ventures investment in Series B - OncoMed Pharmaceuticals

the-vertical-group_image

The Vertical Group

The Vertical Group investment in Series B - OncoMed Pharmaceuticals

us-venture-partners_image

U.S. Venture Partners

U.S. Venture Partners investment in Series B - OncoMed Pharmaceuticals

delphi-ventures_image

Delphi Ventures

Delphi Ventures investment in Series B - OncoMed Pharmaceuticals

bay-partners_image

Bay Partners

Bay Partners investment in Series B - OncoMed Pharmaceuticals

denovo-ventures_image

DeNovo Ventures

DeNovo Ventures investment in Series B - OncoMed Pharmaceuticals

adams-street-partners_image

Adams Street Partners

Adams Street Partners investment in Series B - OncoMed Pharmaceuticals

latterell-venture-partners_image

Latterell Venture Partners

Latterell Venture Partners investment in Series B - OncoMed Pharmaceuticals

latterell-venture-partners_image

Latterell Venture Partners

Latterell Venture Partners investment in Series A - OncoMed Pharmaceuticals

Official Site Inspections

http://www.oncomed.com

  • Host name: 207.232.148.132.host.secureserver.net
  • IP address: 132.148.232.207
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "OncoMed Pharmaceuticals" on Search Engine